Reply to "How to consider the indication of implantable cardioverter defibrillator in the elderly patients".
作者信息
Gotzmann Michael, Lewenhardt Marie, Kreimer Fabienne
机构信息
Department of Cardiology and Rhythmology, St. Josef-Hospital, Ruhr University Bochum, Bochum, Germany.
出版信息
Clin Cardiol. 2024 Dec;47(12):e24208. doi: 10.1002/clc.24208.
Abstract
摘要
相似文献
1
Reply to "How to consider the indication of implantable cardioverter defibrillator in the elderly patients".对《如何考虑老年患者植入式心脏复律除颤器的适应症》的回复
Clin Cardiol. 2024 Dec;47(12):e24208. doi: 10.1002/clc.24208.
2
Dutch Outcome in Implantable Cardioverter-Defibrillator Therapy: Implantable Cardioverter-Defibrillator-Related Complications in a Contemporary Primary Prevention Cohort.荷兰植入型心律转复除颤器治疗结果：当代一级预防队列中与植入型心律转复除颤器相关的并发症。
J Am Heart Assoc. 2021 Apr 6;10(7):e018063. doi: 10.1161/JAHA.120.018063. Epub 2021 Mar 31.
3
Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.皮下植入式心律转复除颤器在困难临床情况下预防心源性猝死的适应证：法国专家立场文件。
Arch Cardiovasc Dis. 2020 May;113(5):359-366. doi: 10.1016/j.acvd.2020.03.011. Epub 2020 Apr 22.
4
Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study.患者对植入式心脏复律除颤器停用讨论的看法：一项定性研究。
SAGE Open Med. 2016 Apr 7;4:2050312116642693. doi: 10.1177/2050312116642693. eCollection 2016.
5
The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication.对于所有有植入式心脏复律除颤器适应症的患者，均应考虑植入皮下植入式心脏复律除颤器。
Heart Rhythm O2. 2022 Oct 21;3(5):589-596. doi: 10.1016/j.hroo.2022.09.006. eCollection 2022 Oct.
6
Disparities in the use of primary prevention and defibrillator therapy among blacks and women.黑人和女性在一级预防及除颤器治疗的使用方面存在差异。
Am J Med. 2006 Feb;119(2):167.e17-21. doi: 10.1016/j.amjmed.2005.08.021.
7
Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis.皮下与传统心脏除颤器的疗效和并发症：系统评价和荟萃分析。
Curr Cardiol Rev. 2022;18(3):e081221198647. doi: 10.2174/1573403X17666211208100151.
8
STEPWISE CARDIAC REHABILITATION ADJUSTMENT AFTER EXERCISE-INDUCED IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SHOCK: A CASE REPORT.运动诱发植入式心脏复律除颤器电击后逐步进行心脏康复调整：一例报告
J Rehabil Med Clin Commun. 2025 Apr 16;8:42483. doi: 10.2340/jrm-cc.v8.42483. eCollection 2025.
9
Use of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrest.植入式心脏复律除颤器在加拿大和美国院外心脏骤停幸存者中的应用。
CMAJ. 2007 Jul 3;177(1):41-6. doi: 10.1503/cmaj.060730.
10
How to consider the indication of implantable cardioverter-defibrillator in the elderly patients.如何看待老年患者植入式心脏复律除颤器的适应证。
Clin Cardiol. 2024 Feb;47(2):e24201. doi: 10.1002/clc.24201. Epub 2023 Dec 12.
本文引用的文献
1
Benefit of primary and secondary prophylactic implantable cardioverter defibrillator in elderly patients.老年患者植入式心脏复律除颤器一级和二级预防的获益。
Clin Cardiol. 2024 Feb;47(2):e24191. doi: 10.1002/clc.24191. Epub 2023 Nov 14.
2
Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations.老年人植入式心脏转复除颤器：基本原理和特定与年龄相关的考虑因素。
Europace. 2015 Feb;17(2):174-86. doi: 10.1093/europace/euu296. Epub 2014 Dec 5.
3
Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators.荟萃分析：预防性植入式心脏除颤器的年龄和效果。
Ann Intern Med. 2010 Nov 2;153(9):592-9. doi: 10.7326/0003-4819-153-9-201011020-00009.
4
Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.植入式除颤器在有危及生命的室性心律失常病史的老年患者中的作用。
Eur Heart J. 2007 Jul;28(14):1746-9. doi: 10.1093/eurheartj/ehl438. Epub 2007 Feb 5.
Zotero 插件